Can excess glucocorticoid, in utero, predispose to cardiovascular and metabolic disease in middle age

Trends in Endocrinology and Metabolism

Volumn 10, Issue 3, 1999, Pages 86-91

  Dodic, Miodrag ^a   Peers, Arianne ^a   Coghlan, John P ^b   Wintour, Marelyn ^a  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID;

CARDIOVASCULAR DISEASE; CHILD BEHAVIOR; DISEASE PREDISPOSITION; HYPERTENSION; INTRAUTERINE GROWTH RETARDATION; METABOLIC DISORDER; NONHUMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SHEEP; STRESS;

EID: 0032980499     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(98)00125-8     Document Type: Review

References (61)

1. Barker D.J.P. Fetal nutrition and cardiovascular disease in later life. Br. Med. Bull. 53:1997;96-108.
2. Seckl J.R. Glucocorticoids, fetoplacental 11β-hydroxysteroid dehydrogenase type 2, and the early life origins of adult disease. Steroids. 62:1997;89-94.
3. Langley-Evans S.C. Intrauterine programming of hypertension by glucocorticoids. Life Sci. 60:1997;1213-1221.
4. Robinson J.S., Owens J.A., McMillen I.C. Back to the womb. Today's Life Science. 9:1997;18-25.
5. Gluckman P.D., Harding J.E. Fetal growth retardation: underlying endocrine mechanisms and postnatal consequences. Acta Paediatr. Suppl. 442:1997;69-72.
6. Weinstock M., Fride E., Hertzberg R. Prenatal stress effects on functional development of the offspring. Prog. Brain Res. 73:1988;319-330.
7. de Kloet E.R., Joels M. Corticosteroid hormones in neuroprotection and brain damage. Curr. Opin. Endocrinol. Diabetes. 3:1996;184-192.
8. Barker D.J.P.et al. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. Br. Med. J. 298:1989;564-567.
9. Barker D.J.P.et al. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to fetal growth. Diabetologia. 36:1993;62-67.
10. Ravelli A.C.J. Glucose tolerance in adults after prenatal exposure to famine. Lancet. 351:1998;173-177.
11. Law C.M., Shiell A.W. Is blood pressure inversely related to birth weight? The strength of evidence from systematic review of the literature. J. Hypertens. 14:1996;935-941.
12. Stanner S.A.et al. Does malnutrition in utero determine diabetes and coronary heart disease in adulthood? Results from the Leningrad siege study, a cross sectional study. Br. Med. J. 315:1997;1342-1349.
13. Rich-Edwards J.W.et al. Birth weight and risk of cardiovascular disease in a cohort of women followed up since 1976. Br. Med. J. 315:1997;396-400.
14. Phillips D.I.W., Barker D.J.P. Association between low birthweight and high resting pulse in adult life: is the sympathetic nervous system involved in programming of the insulin resistance syndrome? Diabetes Med. 14:1997;673-677.
15. Phillips D.I.W.et al. Elevated plasma cortisol concentrations: a link between birth weight and the insulin resistance syndrome? J. Clin. Endocrinol. Metab. 83:1998;757-760.
16. Hawkins P.et al. Cardiovascular development in late gestation fetal sheep and young lambs following modest maternal nutrient restriction in early gestation. J. Physiol. 505P:1997;18. (abstr.).
17. Holemans K., van Bree R., Verhaeghe J., Meurrens K., van Assche A.F. Maternal semistarvation and streptozotocin-diabetes in rats have different effects on the in vivo glucose uptake by peripheral tissues in their female adult offspring. J. Nutr. 127:1997;1371-1376.
18. Burns S.P.et al. Gluconeogenesis, glucose handling, and structural changes in livers of adult offspring of rats partially deprived of protein during pregnancy and lactation. J. Clin. Invest. 100:1997;1768-1774.
19. Whitworth J.A., Brown M.A., Kelly J.J., Williamson P.M. Mechanisms of cortisol-induced hypertension in humans. Steroids. 60:1995;76-80.
20. Walker B.R.et al. Increased glucocorticoid activity in men with cardiovascular risk factors. Hypertension. 31:1998;891-895.
21. Jacobson L., Zurakowski D., Majzoub J.A. Protein malnutrition increases plasma adrenocorticotrophin and anterior pituitary proopiomelanocortin messenger ribonucleic acid in the rat. Endocrinology. 138:1997;1048-1057.
22. Langley-Evans S.C. Maternal carbenoxolone treatment lowers birthweight and induces hypertension in the offspring of rats fed a protein-replete diet. Clin. Sci. 93:1997;423-429.
23. Langley-Evans S.C. Hypertension induced by fetal exposure to a maternal low-protein diet, in the rat, is prevented by pharmacological blockade of maternal glucocorticoid synthesis. J. Hypertens. 15:1997;537-544.
24. Levitt N.S., Linsay R.S., Holmes M.C., Seckl J.R. Dexamethasone in the last week of pregnancy attenuates hippocampal glucocorticoid receptor gene expression and elevates blood pressure in the adult offspring in the rat. Neuroendocrinology. 64:1996;412-418.
25. Dodic M., May C.N., Wintour E.M., Coghlan J.P. An early prenatal exposure to excess glucocorticoid leads to hypertensive offspring in sheep. Clin. Sci. 94:1998;149-155.
26. Kosut S.S., Wood R.I., Herbosa-Encarnacion C., Foster D.L. Prenatal androgens time neuroendocrine puberty in the sheep: effect of testosterone dose. Endocrinology. 138:1997;1072-1077.
27. Wintour E.M. The renin- angiotensin system and the development of the kidney. Trends Endocrinol. Metab. 8:1997;199-207.
28. Schutz S., LeMoullec J.M., Corvol P., Gase J.M. Early expression of all the components of the renin-angiotensin-system in human development. Am. J. Pathol. 149:1996;2067-2079.
29. Reid I.A. Interactions between Ang II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. Am. J. Physiol. 262:1992;E763-E778.
30. Tait J.F., Tait S.A.S. Insulin, the renin-angiotensin-aldosterone system and blood pressure. Perspect. Biol. Med. 40:1997;246-259.
31. Kingdom J.C.P., McQueen J., Connell J.M.C., Whittle M.J. Fetal angiotensin II levels and vascular (type I) angiotensin receptors in pregnancies complicated by intrauterine growth retardation. Br. J. Obstet. Gynaecol. 100:1993;476-482.
32. Konje J.C., Bell S.C., Morton J.J., de Chazal R., Taylor D.J. Human fetal kidney morphometry during gestation and relationship between weight, kidney morphometry and plasma active renin concentration at birth. Clin. Sci. 91:1996;169-175.
33. MacKenzie H.S., Lawler E.V., Brenner B.M. Pathogenesis and pathophysiology of essential hypertension. Congenital oligonephropathy: the fetal flaw in essential hypertension? Kidney Int. 49:1996;S30-S34.
34. Sherman R.C., Langley-Evans S.C. Early administration of angiotensin-converting enzyme inhibitor captopril, prevents the development of hypertension programmed by intrauterine exposure to a maternal low-protein diet in the rat. Clin. Sci. 94:1998;373-381.
35. dos Santos C.M., Moreira E.D., Krieger E.M., Michelini L.C. Chronic AT1 receptor blockade alters aortic nerve activity in hypertension. Hypertension. 31:1998;973-977.
36. Meaney M.J.et al. Early environmental programming of hypothalamic-pituitary-adrenal responses to stress. Semin. Neurosci. 6:1994;247-259.
37. Muneoka K.et al. Prenatal dexamethasone exposure alters brain monoamine metabolism and adrenocortical response in rat offspring. Am. J. Physiol. 273:1997;R1669-R1675.
38. Uno H.et al. Neurotoxicity of glucocorticoids in the primate brain. Horm. Behav. 28:1994;336-348.
39. Hawkins P.et al. Effect of maternal nutrient restriction in early gestation on hypothalamic pituitary adrenal axis responses during acute hypoxaemia in late gestation fetal sheep. J. Physiol. 507P:1998;50. (abstr.).
40. Scaglia L., Cahill C.J., Finegood D.T., Bonner-Weir S. Apoptosis participates in the remodeling of the endocrine pancreas in the neonatal rat. Endocrinology. 138:1997;1736-1741.
41. Tornehave D., Larsson L.I. Presence of Bcl-x1 during development of the human fetal and rat neonatal endocrine pancreas; correlation to programmed cell death. Exp. Clin. Endocrinol. Diabetes. 105:1997;A27. (abstr.).
42. Petrick J., Arany E., McDonald T.J., Hill D.J. Apoptosis in the pancreatic islets of the neonatal rat is associated with reduced expression of insulin-like growth factor II that may act as a survival factor. Endocrinology. 139:1998;2994-3004.
43. 3H]-dexamethasone in bovine tissues is not to classical glucocorticoid receptors. Endocrinology. 105:1979;827-834.
44. Kliewer S.A.et al. An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell. 92:1998;73-82.
45. Baulieu E.E. Neurosteroids: of the nervous system, by the nervous system, for the nervous system. Rec. Prog. Horm. Res. 52:1997;1-32.
46. Poletti A., Negri-Cesi P., Rabuffetti M., Colciago A., Celotti F., Martini L. Transient expression of the 5α-reductase type 2 isozyme in the rat brain in late fetal and early postnatal life. Endocrinology. 139:1998;2171-2178.
47. Huss J.M., Wang S.I., Astrom A., McQuiddy P., Kasper C.B. Dexamethasone responsiveness of a major glucocorticoid-inducible CYP3A gene is mediated by elements unrelated to a glucocorticoid receptor binding motif. Proc. Natl. Acad. Sci. U. S. A. 93:1996;4666-4670.
48. Wehling M. Specific nongenomic actions of steroid hormones. Annu. Rev. Physiol. 59:1997;365-393.
49. Laiprasert J.D., Rogers R.C., Heesch C.M. Neurosteroid modulation of arterial baroreflex-sensitive neurons in rat rostral ventrolateral medulla. Am. J. Physiol. 274:1998;R903-R911.
50. Seckl J.R., Miller W.L. How safe is long-term prenatal glucocorticoid treatment? J Am. Med. Assoc. 277:1997;1077-1079.
51. Quinlivan J.A., Evans S.F., Dunlop S.A., Beazley L.D., Newnham J.P. Use of corticosteroids by Australian obstetricians - a survey of clinical practice. Aust. New Zealand J. Obstet. Gynaecol. 38:1998;1-7.
52. Dunlop S.A., Archer M.A., Quinlivan J.A., Beazley L.D., Newnham J.P. Repeated prenatal corticosteroids delay myelination in the ovine central nervous system. J. Matern. Fetal Med. 6:1997;309-313.
53. Trautman P.D., Meyer-Bahlburg H.F.L., Postelnek J., New M.I. Effects of early prenatal dexamethasone on the cognitive and behavioural development of young children: results of a pilot study. Psychoneuroendocrinology. 29:1995;439-449.
54. Forest M.G., Morel Y., David M. Prenatal treatment of congenital adrenal hyperplasia. Trends Endocrinol. Metab. 9:1998;284-289.
55. Miller L.M. Prenatal treatment of congenital adrenal hyperplasia: a promising experimental therapy of unproven safety. Trends Endocrinol. Metab. 9:1998;290-293.
56. Dorn D.L., Suman E.J., Petersen A.C. Cortisol reactivity and anxiety and depression in pregnant adolescents: a longitudinal perspective. Psychoneuroendocrinology. 18:1993;219-239.
57. Wadhwa P.D., Dunkel-Schetter C., Chicz-DeMet A., Porto M., Sandman C.A. Prenatal psychosocial factor and the neuroendocrine axis in human pregnacy. Psychosom. Med. 58:1996;432-446.
58. Jamieson A., Slutsker L., Inglis G.C., Fraser R., White P.C., Connell J.M.C. Glucocorticoid-supressible hyperaldosteronism: effects of crossover site and parental origin of chimaeric gene on phenotypic expression. Clin. Sci. 88:1995;563-570.
59. Goodfriend T.L., Egan B., Stepniakowski K., Ball D.L. Relationships among plasma aldosterone, high density lipoprotein cholesterol, and insulin in humans. Hypertension. 25:1995;30-36.
60. Gomez-Sanchez E.P. Central hypertensive effects of aldosterone. Front. Neuroendocrinol. 18:1997;440-462.
61. Chao H.M., Ma L.Y., McEwen B.S., Sakai R. Regulation of glucocorticoid receptor and mineralocorticoid receptor messenger ribonucleic acid by selective agonists in the rat hippocampus. Endocrinology. 139:1998;1810-1814.